CD4 and infection: This led to significantly lower levels of infection of untreated CTV-labeled bystander CD4+ T cells (~0.5% p24+ cells); and iii) treated CTV-labeled bystander CD4+ T cells were protected from infection in the presence of untreated, productively infected CD4+ T cells (2–2.5% HIV+ cells) (Fig. 1I).